Mariner’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97.9K Buy
7,434
+2,204
+42% +$49.2K ﹤0.01% 3335
2026
Q1
$137K Buy
5,230
+4,424
+549% +$556K ﹤0.01% 3263
2025
Q4
$200K Buy
806
+525
+187% +$120K ﹤0.01% 3172
2025
Q3
$59.1K Buy
+281
New +$49.6K ﹤0.01% 3429
2020
Q4
– Sell
-300
Closed -$297K – 792
2020
Q3
$297K Buy
300
+5
+2% +$5.3K ﹤0.01% 672
2020
Q2
$306K Buy
+295
New +$297K ﹤0.01% 672

Other funds holding GOSS

Mariner's GOSS Position: Q2 2026 in Review

Mariner increased its Gossamer Bio (GOSS) stake by 42% in Q2 2026, buying an estimated $49.2K and bringing the position to 7,434 shares worth $97.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3335.

Mariner first reported a position in GOSS in Q2 2020 and has held it in 6 quarters since. The position peaked at $306K in Q2 2020. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Mariner held 7,434 shares of Gossamer Bio worth $97.9K as of Q2 2026.
  • Mariner bought 2,204 Gossamer Bio shares in Q2 2026, an estimated $49.2K.
  • Gossamer Bio made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3335 holding.
  • Mariner first reported a position in Gossamer Bio in Q2 2020 and has held it in 6 quarters since.
  • Mariner's Gossamer Bio position peaked at $306K in Q2 2020.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.